proline and carbostyril

proline has been researched along with carbostyril in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Guo, Q; Wang, M; Wang, W; Wang, X; Weng, J; Xu, X; Ye, X1
Belavic, JM1
Li, J; Wang, J; Xu, Z; Zhu, S1
Binet, L; Djerada, Z; Feliu, C; Gozalo, C; Lamiable, D; Marty, H; Millart, H; Robinet, A; Tournois, C; Vautier, D1
Brunda, M; Chu, T; Elston, R; Gane, EJ; George, J; Glavini, K; Hammond, JM; Jensen, DM; Le Pogam, S; Nájera, I; Passe, S; Piekarska, A; Rodriguez, I; Zeuzem, S1
Almond, LM; Beringer, PM; Chung, PS; Hong, E; Rao, AP1

Trials

1 trial(s) available for proline and carbostyril

ArticleYear
Interferon-free regimens containing setrobuvir for patients with genotype 1 chronic hepatitis C: a randomized, multicenter study.
    Liver international : official journal of the International Association for the Study of the Liver, 2016, Volume: 36, Issue:4

    Topics: Adult; Antiviral Agents; Australia; Benzothiadiazines; Cyclopropanes; Deoxycytidine; Drug Therapy, Combination; Europe; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Isoindoles; Lactams; Lactams, Macrocyclic; Male; Middle Aged; New Zealand; Phenotype; Proline; Quinolones; Remission Induction; Ribavirin; RNA, Viral; Sulfonamides; Time Factors; Treatment Outcome; United States; Viral Load

2016

Other Studies

5 other study(ies) available for proline and carbostyril

ArticleYear
A mutational analysis and molecular dynamics simulation of quinolone resistance proteins QnrA1 and QnrC from Proteus mirabilis.
    BMC structural biology, 2010, Oct-08, Volume: 10

    Topics: Amino Acid Sequence; Bacterial Proteins; Base Sequence; DNA Mutational Analysis; Drug Resistance, Bacterial; Models, Molecular; Molecular Dynamics Simulation; Molecular Sequence Data; Mutagenesis; Proline; Protein Conformation; Proteus mirabilis; Quinolones; Sequence Alignment

2010
Annual drug update: 2011 in review.
    The Nurse practitioner, 2012, Feb-12, Volume: 37, Issue:2

    Topics: Abatacept; Aminoglycosides; Carbamates; Drug Approval; Fentanyl; Fidaxomicin; Humans; Immunoconjugates; Indans; Linagliptin; Phenylenediamines; Proline; Purines; Quinazolines; Quinolones; United States; United States Food and Drug Administration

2012
An efficient one-pot synthesis of pyrano[3,2-c]quinolin-2,5-dione derivatives catalyzed by L-proline.
    Molecules (Basel, Switzerland), 2012, Nov-22, Volume: 17, Issue:12

    Topics: Aldehydes; Catalysis; Dioxanes; Hydroquinones; Molecular Structure; Proline; Pyrans; Quinolones; Structure-Activity Relationship

2012
Validation of a fast method for quantitative analysis of elvitegravir, raltegravir, maraviroc, etravirine, tenofovir, boceprevir and 10 other antiretroviral agents in human plasma samples with a new UPLC-MS/MS technology.
    Journal of pharmaceutical and biomedical analysis, 2013, Volume: 86

    Topics: Adenine; Anti-Retroviral Agents; Chromatography, High Pressure Liquid; Cyclohexanes; Humans; Maraviroc; Mass Spectrometry; Nitriles; Organophosphonates; Proline; Pyridazines; Pyrimidines; Pyrrolidinones; Quinolones; Raltegravir Potassium; Tandem Mass Spectrometry; Tenofovir; Time Factors; Triazoles

2013
Physiologically-Based Pharmacokinetic-Led Guidance for Patients With Cystic Fibrosis Taking Elexacaftor-Tezacaftor-Ivacaftor With Nirmatrelvir-Ritonavir for the Treatment of COVID-19.
    Clinical pharmacology and therapeutics, 2022, Volume: 111, Issue:6

    Topics: Aminophenols; Benzodioxoles; Chloride Channel Agonists; COVID-19 Drug Treatment; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Cytochrome P-450 CYP3A; Drug Combinations; Drug Interactions; Humans; Indoles; Lactams; Leucine; Mutation; Nitriles; Proline; Pyrazoles; Pyridines; Pyrrolidines; Quinolines; Quinolones; Ritonavir

2022